The Global Nonalcoholic Fatty Liver Disease (NAFLD) Therapeutics Market is evolving rapidly, driven by the increasing prevalence of obesity, type 2 diabetes, and metabolic syndrome. NAFLD, a chronic liver condition characterized by the buildup of fat in the liver without significant alcohol consumption, has become a global health challenge. With advancements in therapeutics and diagnostics, the...

Exploring the Future of Antisense RNAi Therapeutics Market The Global Antisense RNAi Therapeutics Market is on a remarkable growth trajectory, revolutionizing medical treatments through cutting-edge genetic technologies. This market research report delves into the intricate segmentation and forecasts trends until 2032. Market Segmentation Highlights Antisense RNAi Therapeutics Market...

Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions.   Roots Analysis is pleased to announce the publication of its recent study titled, “Digital Health Market: Focus on Digital Therapeutics...

Digital Therapeutics was valued at USD 6.17 billion in 2023 and is projected to reach USD 41.20 billion by 2031, growing at a CAGR of 27.23% from 2024 to 2031. The market is experiencing robust growth, driven by technological advancements, the rising prevalence of chronic diseases, and the increasing adoption of digital health solutions.  Digital Therapeutics Market Top 10 Companies:...

Global Digital Therapeutics Market The GMI Research forecasts that the Digital Therapeutics Market is witnessing an upsurge in demand over the forecast period. This is mainly due to the growing number of internet users, the rising need to curb healthcare expenditures, improved drug adherence, and the increasing use of smartphones. Introduction of the Digital Therapeutics Market Digital...

So far, more than 100 different types of cannabinoids have been identified and there is a growing body of evidence supporting the benefits of this class of compounds in offering symptomatic relief for a wide variety of chronic health conditions   London   Roots Analysis has announced the addition of “Endocannabinoid System Targeted Therapeutics Market, 2020-2030” report to...

Report Keyword - Global, Digital, Therapeutics, Roots Analysis, Report   Recent advances in information technology and biomedical science have enabled the development of a number of versatile digital solutions that are capable of either mimicking or augmenting, the fundamental qualities of pharmacological interventions   Roots Analysis has announced the addition of “Digital...

Global Digital Therapeutics Market The GMI Research forecasts that the Digital Therapeutics Market is witnessing an upsurge in demand over the forecast period. This is mainly due to the growing number of internet users, the rising need to curb healthcare expenditures, improved drug adherence, and the increasing use of smartphones. Request a free sample of this report Introduction of the Digital...

The new report by Expert Market Research titled, ‘Global Malignant Mesothelioma Therapeutics Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global malignant mesothelioma therapeutics market, assessing the market based on its segments like products, application, and major regions like Asia Pacific, Europe, North America, Middle East and Africa and Latin...

Global Protein Therapeutics Market Research Report: By Type (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Others), By Application (Cancer, Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Others), By Protein Function (Enzymatic and Regulatory Activity, Special Targeting Activity, Vaccines, Others), By End User (Hospitals and Clinics, Specialty...

Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2021–2030.” The report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It...